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With Clinical and Cardiac Characteristics and Impact
on CMR Measures of LV Anatomy and Function
Michael L. Chuang, MD,*†‡ Philimon Gona, PHD,*§ Gilion L. T. F. Hautvast, PHD,
Carol J. Salton, AB,† Susan J. Blease, MPH,* Susan B. Yeon, MD, JD,† Marcel Breeuwer, PHD,
Christopher J. O’Donnell, MD, MPH,*¶‡ Warren J. Manning, MD†‡#
Framingham and Boston, Massachusetts; and Best, the Netherlands
O B J E C T I V E S The goal of this study was to assess the relationship of left ventricular (LV) trabeculae and
papillary muscles (TPM) with clinical characteristics in a community-based, free-living adult cohort and to
determine the effect of TPM on quantitative measures of LV volume, mass, and ejection fraction (EF).
B A C KG ROUND Hypertrabeculation has been associated with adverse cardiovascular events, but
the distribution and clinical correlates of the volume and mass of the TPM in a normal left ventricle have
not been well characterized.
METHOD S Short-axis cine cardiac magnetic resonance images, obtained using a steady-state free
precession sequence from 1,494 members of the Framingham Heart Study Offspring cohort, were
analyzed with software that automatically segments TPM. Absolute TPM volume, TPM as a fraction of
end-diastolic volume (EDV) (TPM/EDV), and TPM mass as a fraction of LV mass were determined in all
offspring and in a referent group of offspring free of clinical cardiovascular disease and hypertension.
R E S U L T S In the referent group (mean age 61  9 years; 262 men and 423 women), mean TPM was
23  3% of LV EDV in both sexes (p  0.9). TPM/EDV decreased with age (p  0.02) but was not
associated with body mass index. TPM mass as a fraction of LV mass was inversely correlated with age
(p  0.0001), body mass index (p  0.018), and systolic blood pressure (p  0.0001). Among all 1,494
participants (699 men), LV volumes decreased 23%, LV mass increased 28%, and EF increased by 7.5 EF
units (p  0.0001) when TPM were considered myocardial mass rather than part of the LV blood pool.
CONC L U S I O N S Global cardiac magnetic resonance LV parameters were signiﬁcantly affected by
whether TPM was considered as part of the LV blood pool or as part of LV mass. Our cross-sectional data
from a healthy referent group of adults free of clinical cardiovascular disease demonstrated that
TPM/EDV decreases with increasing age in both sexes but is not related to hypertension or
obesity. (J Am Coll Cardiol Img 2012;5:1115–23) © 2012 by the American College of Cardiology
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1116eft ventricular (LV) “hypertrabeculation” has
been associated with adverse cardiovascular out-
comes (1–3) and with extracardiac disease, in-
cluding neuromuscular disorders (4), but the
ormal range of trabeculation and papillary muscle
ass on cardiac magnetic resonance (CMR) imag-
ng has not been fully characterized. In addition, the
ffect of the trabeculae and papillary muscles
TPM) on determination of LV volume, mass, and
See page 1124
ejection fraction (EF) has not been assessed in a large,
community-dwelling population. Cine steady-state
free precession (SSFP) CMR provides
high-resolution imaging of the left ventri-
cle, with excellent visual contrast between
myocardium and LV blood pool (5,6).
These desirable attributes emphasize the
papillary muscles and the trabeculae car-
nae, which were less well-visualized with
other CMR sequences. There is variability
in the treatment of TPM with respect to
quantification of LV mass (LVM) and
EF, important indexes with diagnostic and
prognostic value. The TPM are often
considered part of the LV cavity volume
(i.e., blood pool) because this simplifies
analysis and has been shown to improve
observer reproducibility, particularly with
manual tracing of endocardial contours
(7). Although this is a reasonable ap-
proach for many patients, the proportional
impact of TPM may be greater in select
patient groups, such as those with hyper-
trophic cardiomyopathy (8) or markedly
impaired LV EF (9).
The goal of this study was to determine
the relation of TPM to global LV cavity
size, mass, and global systolic function metrics in a
cohort of free-living adults and to assess the effect of
treating TPM as LV blood pool, versus as myocar-
dial mass, on those LV metrics. We also sought to
determine whether TPM varies with sex, age, body
mass index (BMI), and history of hypertension or
previous adverse cardiovascular events.
M E T H O D S
Study population. The Framingham Heart Study
Offspring cohort was initiated in 1971 and com-
prises 5,124 participants who are the children of the
re
lary
scles
walloriginal cohort or the spouses of those children m(10). Offspring cohort members were eligible for
participation in the CMR substudy if they attended
the seventh offspring cycle examination (1998 to
1999, N  3,799), were in sinus rhythm, and had
no contraindications to CMR. A total of 1,794
offspring underwent CMR from 2002 to 2006.
All participants provided written informed con-
sent, and the study was approved by the institu-
tional review boards of the Beth Israel Deaconess
Medical Center and the Boston University Med-
ical Center.
Clinical covariates and medication information
(blood pressure, height, weight, BMI, and antihy-
pertensive drug treatment) were collected in a
structured examination by a physician during the
seventh cycle examination. Hypertension was defined
as a systolic blood pressure (SBP) 140 mm Hg or
iastolic blood pressure 90 mm Hg on the mean
f 2 measurements by a physician or use of antihy-
ertensive medication. Data regarding cardiovascu-
ar disease events, such as myocardial infarction and
eart failure, were collected and reviewed. All
ardiovascular disease events were adjudicated by a
anel of 3 physicians who were blinded to par-
icipant CMR data and who used standardized
riteria (11).
CMR imaging. Participants underwent supine CMR
scanning using a 1.5-T system with a 5-element
cardiac array coil for radiofrequency signal reception
(Gyroscan NT, Philips Healthcare, Best, the Neth-
erlands). After scout imaging to determine the
orientation of the heart within the thorax, a con-
tiguous stack of short-axis two-dimensional SSFP
cine images, encompassing the left ventricle from
apex to base, was obtained. Imaging parameters
included: TR  3.2 ms, TE  1.6 ms, and flip
angle  60°. Slice thickness was 10 mm (no
nterslice gap) with 1.9-  1.6-mm2 in-plane spa-
ial resolution.
Image analysis. Images were transferred to a dedi-
ated workstation (Extended MR Workspace 2009,
hilips Healthcare) for analysis. Epicardial and
ndocardial LV contours were delineated across the
ardiac cycle using an automated contour detection
lgorithm followed by manual correction as needed.
he automated contour detection method was ap-
lied to the LV short-axis images only and has been
reviously described (12). Briefly, it models the
hort-axis myocardium as a ribbon of variable
idth, with the inner (endocardial) and outer (epi-
ardial) contours described by interpolation of aA B B R E V I A T I O N S
A N D A C R O N YM S
BMI bodymass index
CMR cardiac magnetic
resonance
EDV end-diastolic volume
EF ejection fraction
ESV end-systolic volume
HTN participants with
history of hypertension
ICC intraclass correlation
coefficient
LV left ventricular
LVM left ventricular mass
SBP systolic blood pressu
SSFP steady-state free
precession
TPM trabeculae and papil
muscles
TPMm calculated mass of
trabeculae and papillary mu
WMA participants withinimal number of splines for each. An energy-
t
T
h
m
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1117minimizing criterion that favors smooth, circular
shapes, combined with regional constraints favoring
homogeneous segmentation, results in contours
that treat TPM as part of the LV blood pool. The
automated analysis (which can be manually cor-
rected as needed) agrees well with fully manual
analysis, with correlation coefficients of 0.99 for
LV end-diastolic volume (EDV) and end-systolic
volume (ESV), 0.96 for LVM, and 0.97 for LV
EF (12).
The initial segmentation (INIT), which consid-
ered TPM as part of the LV blood pool, was used
to determine EDVINIT, ESVINIT, EFINIT, and
LVMINIT. The TPM volume was then quantified
using a fuzzy thresholding algorithm (12) based on
the difference between bright blood pool and darker
myocardial intensities; the threshold was deter-
mined on the basis of image characteristics.
Thresholds are examination specific; there are no
pre-determined global cutpoints for myocardium
versus blood pool. Figure 1 shows 2 examples of
Figure 1. Examples of TPM Quantitation
(A) End-diastolic mid–left ventricular (LV) slice from a relatively ligh
epicardial border detection and segmentation of trabeculae and pa
pool (slice end-diastolic volume [EDV]ADJ) is shown in white. For th
whereas slice EDVADJ 19.9 ml and LVMADJ  17.5g. (C and D) A m
LVMINIT  17.4 g; after TPM segmentation slice EDVADJ  12.1 ml andTPM segmentation. Although the sample figures
are posterized (black or white) to emphasize trabec-
ular fine details, the actual algorithm used to deter-
mine TPM volume accounts for partial volume
effects. Finally, LV parameters were adjusted (ADJ)
by subtracting TPM volume from LV volume at
each phase, yielding EDVADJ and ESVADJ, and the
calculated mass of TPM (TPMm  TPM vol-
ume  1.05 g/ml) was added to LVM, yielding
LVMADJ. LV EFADJ was computed from EDVADJ
and ESVADJ. All image data were analyzed by a
single experienced operator (C.J.S.) who was un-
aware of participant characteristics.
Statistical analysis. Data were analyzed using SAS
version 9.2 (SAS Institute, Inc., Cary, North Car-
olina). Continuous data were checked for normality
and summarized as mean  SD. Pearson correla-
ion was used to assess linear relationships between
PM and clinical characteristics. We defined a
ealthy referent group, free of any history of prior
yocardial infarction or heart failure, any wall
rabeculated participant. (B) The same slice after endocardial and
ry muscles (TPM); TPM are shown in black and the residual blood
ice, EDVINIT  24.6 ml and left ventricular mass (LVM)INIT  12.5 g,
heavily trabeculated participant with slice EDVINIT  21.5 ml andtly t
pilla
is sl
oreLVMADJ  27.3 g.
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1118motion abnormality (of 2 anatomically contigu-
ous segments) on CMR, and any history of hyper-
tension to determine the amount of TPM, and its
effect on LV EF and LVM, in this putatively
normal group. Global LV and TPM measures were
compared between the sexes and within-sex be-
tween referent and nonreferent participants using
the 2-sample t test with equal or unequal variance
as indicated. Pairs of unadjusted and adjusted LV
parameters were compared using the paired t test.
Linear correlations were assessed using Pearson
correlation coefficients. Reproducibility was as-
sessed by intraclass correlation coefficient (ICC)
on a subsample of 48 participants randomly
selected from equal strata of sex and age-tertile.
A p value 0.05 was considered statistically
ignificant.
R E S U L T S
Study cohort. Data from 1,494 consecutive off-
pring undergoing CMR were analyzed for this
tudy. In this cohort, 53 (3.6%) had a documented
rior myocardial infarction or heart failure, 125
8.4%) had a focal LV wall motion abnormality on
MR, and 785 (52.5%) had documented hyperten-
ion or use of antihypertensive medication. Appli-
ation of these exclusion criteria left 262 men
38.2%) and 423 women (61.8%) in the healthy
eferent group. A particular participant could
ave 1 criterion for exclusion from the referent
roup. The clinical characteristics of the referent
nd nonreferent groups, as well as the study
opulation as a whole, are shown in Table 1.
here were differences between men and women
acteristics of the REF Group and the Entire Study Population
Men (REF)
(n  262)
Women (REF)
(n  423)
Men (Non-REF)
(n  437)
60.6 8.5 61.7 8.6* 67.4 8.6†
1.76 0.07 1.62 0.06‡ 1.74 0.06§
84.6 14.0 67.9 12.4‡ 88.7 14.0†
27.2 3.5 25.8 4.4‡ 29.1 4.3†
117 10 114 12* 132 17†
73 11 70 8‡ 77 11†
NA NA 96.3
NA NA 21.7
NA NA 9.8
%. *p  0.05 between men and women of corresponding groups (e.g., Men [REF]
and women of corresponding groups (e.g., Men [REF] versus Women [REF]); §p
DBP  diastolic blood pressure; HTN  presence of any antecedent hypertensio
eart failure; NA  not applicable; non-REF  participants not in the referent gro
blood pressure; WMA  having a cardiovascular magnetic resonance focal wall mon anthropometric and blood pressure measures,
s expected.
Global LV and TPM measures. Table 2 displays the
lobal LV parameters in referent-group men and
omen. In the referent group, EDVINIT, ESVINIT,
nd LVMINIT were greater in men than in women,
hereas EFINIT was greater in women. LVMINIT
was linearly correlated with SBP in referent men
(r  0.26) and women (r  0.26) (p  0.0001 for
both) and across all participants (men: r  0.21,
women: r  0.31; p  0.0001 for both). TPM was
greater in men than in women, but TPM volume as
a fraction of EDVINIT (TPM/EDV) did not differ
etween sexes. TPMm as a fraction of LVMINIT
(TPMm/LVM) was slightly but significantly
greater in women than men.
After subtraction of TPM volume (ADJ) we
expected EDV to decrease, and LVM to increase
with the addition of TPMm. In the referent group,
EDV decreased by an average of 23% in both sexes,
whereas LVM increased 30% and LV EF increased
by 7.5 EF units after ADJ. Changes of the same
direction and similar magnitude were seen post-
ADJ across the study group as a whole (Table 2).
Post-ADJ LV volumes and mass remained greater
in men versus women. LV EF increased after ADJ
in both sexes, and EFADJ remained greater in
women than in men. EFINIT and EFADJ were
highly correlated with one another among men (r
0.95, p  0.0001) and among women (r  0.92,
p  0.0001).
Reproducibility of TPM measures. Intraobserver
ICCs were 0.99, 0.99, 0.99, and 0.97 for EDVADJ,
SVADJ, LVMADJ, and EFADJ, respectively. Inter-
observer ICCs were 0.99 for EDVADJ, 0.98 for
SVADJ, 0.99 for LVMADJ, and 0.96 for EFADJ.
Women (Non-REF)
(n  372)
Men, All
(n  699)
Women, All
(n  795)
67.8 8.3† 64.9 9.1 64.6 9.0‡
1.60 0.06† 1.75 0.06 1.61 0.06‡
74.7 16.5† 87.2 13.4 71.1 14.8‡
29.0 6.0† 28.4 4.1 27.3 5.4‡
135 19† 126 17 124 19*
75 11† 76 10 72 10*
97.8 60.2 45.8
8.1 13.6 3.8
2.7 6.2 1.3
us Women [REF]); †p  0.001 within-sex difference between REF and non-REF;
5 within-sex difference between REF and non-REF.
use of antihypertensive medications; MIHF  positive history of adjudicated
EF  healthy referent group (members were free of HTN, WMA, and MIHF byTable 1. Clinical Char
Age, yrs
Height, m
Weight, kg
BMI, kg/m2
SBP, mm Hg
DBP, mm Hg
HTN, %
WMA, %
MIHF, %
Values are mean  SD or vers
‡p  0.001 between men  0.0
BMI  body mass index; n or
myocardial infarction or h up; R
tion abnormality.
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1119Variation in global LV and TPM measures with hyper-
tension and focal LV dysfunction. Sex-specific com-
parisons of referent participants to those with his-
tory of hypertension (HTN) and those with wall
motion abnormalities (WMA) are presented in
Table 3. In each sex, the referent-group participants
were younger than those in the HTN and
WMA groups. As expected, referent participants
also had lower BMI and had lower SBP than the
HTN or the WMA groups. EDVINIT, ESVINIT,
and LVMINIT were greater in the WMA versus
eferent groups for both men and women, whereas
FINIT was lower in the WMA group. The
Table 2. Global LV Parameters in Men and Women in the REF G
Parameter
REF Men
(n  262)
REF Women
(n  423)
EDVINIT (ml) 143 25 107 18
EDVADJ (ml) 111 19 83 15
ESVINIT (ml) 49 13 35 9
ESVADJ (ml) 30 10 20 7
LV EFINIT (%) 66.0 5.3 68.0 5.0
LV EFADJ (%) 73.4 6.5* 75.6 5.9*
LVMINIT (g) 123 22 81 15
LVMADJ (g) 157 26 107 18
TPM (ml) 33 8 24 5
TPM/EDV 0.23 0.03 0.23 0.03
TPMm/LVM 0.28 0.07 0.32 0.06
TPM/BSA (ml/m2) 16.2 3.9 13.9 2.6
*EFADJ  EFINIT, p  0.0001.
ADJ  trabecular and papillary muscles considered as myocardial mass; BSA
trabecular and papillary muscles considered as part of left ventricular blood poo
and papillary muscles; other abbreviations as in Table 1.
Table 3. Global LV Parameters in Men and Women With Hypert
Men: REF
(n  262)
Men: HTN
(n  421)
Age, yrs 60.6 8.5 67.6 8.5*
BMI, kg/m2 27.2 3.5 29.2 4.3*
SBP, mm Hg 117 10 132 17*
EDVINIT, ml 143 25 147 31
EDVADJ, ml 111 19 115 26†
ESVINIT, ml 49 13 52 21†
ESVADJ, ml 30 10 33 17†
EFINIT, % 66.0 5.3 65.3 8.4
EFADJ, % 73.4 6.5 72.4 9.7
LVMINIT, g 123 22 132 27*
LVMADJ, g 157 26 166 32*
TPM, ml 33 8 33 9
TPM/EDV 0.23 0.03 0.22 0.04†
TPMm/LVM 0.28 0.07 0.26 0.07*
TPM/BSA, ml/m2 16.2 3.9 15.7 4.1
*p  0.001, †p  0.05 versus REF within each sex. (Some participants overlap
EF  ejection fraction; other abbreviations as in Tables 1 and 2.HTN group had greater LVMINIT than the
referent group; EFINIT was slightly higher in refer-
nt women versusHTN women but did not differ
mong men.
Absolute TPM volume was significantly greater
n WMA versus referent men (p  0.0002); a
imilar pattern was seen among women, but this
nding was only of borderline significance (p 
.03). TPM/EDV was similar in magnitude among
oth men and women, with at most borderline
ecreases associated with HTN or WMA.
PMm/LVM was significantly lower in men (p 
.0003) and women (p  0.0001) with HTN
p and Among All Participants
p Value:
n Versus Women
All Men
(n  699)
All Women
(n  795)
0.0001 146 29 108 20
0.0001 113 24 84 16
0.0001 52 19 34 11
0.0001 32 15 20 8
0.0001 65 7 69 6
0.0001 72 9* 76 7*
0.0001 129 26 86 17
0.0001 163 30 112 20
0.0001 33 9 24 6
0.90 0.22 0.04 0.23 0.04
0.0001 0.27 0.07 0.30 0.07
0.0001 16.7 4.3 14.4 3.1
ody surface area; EDV  end-diastolic volume; EF  ejection fraction; ESV  en
M  left ventricular mass; TPM  trabecular and papillary muscles; TPMm  calc
ion or CMR LV Wall-Motion Abnormality Compared With the REF
Men: WMA
(n  95)
Women: REF
(n  423)
Women: HTN
(n  423)
67.6 9.1* 61.7 8.6 67.9 8.3*
29.0 4.3* 25.8 4.4 29.2 6.0*
128 19* 114 12 136 18*
166 34* 107 18 110 21
129 29* 83 15 85 18
76 28* 35 9 33 12
52 24* 20 7 19 9
55.2 9.6* 68.0 5.0 70.2 6.4*
61.1 11.7* 75.6 5.9 77.6 7.5*
144 29* 81 15 92 18*
182 34* 107 18 118 22*
37 10* 24 5 25 6
0.23 0.05 0.23 0.03 0.22 0.04
0.28 0.08 0.32 0.06 0.28 0.07*
18.0 4.8* 13.9 2.6 13.5 3.2
th the HTN and WMA groups.)rou
Me
p Value:
Men Versus Women
0.0001
0.0001
0.0001
0.0001
0.0001
0.0001
0.0001
0.0001
0.0001
0.22
0.0001
0.0001
 b d-systolic volume; INIT 
l; LV ulated mass of trabeculaeens Group
Women: WMA
(n  30)
69.1 8.6*
28.6 6.3†
132 21*
127 32†
100 26†
53 20*
35 14*
59.7 8.4*
65.8 8.8*
103 27*
132 32*
27 7†
0.22 0.04†
0.28 0.07†
15.0 3.8†
in bo
wi
i
w
Abbreviations as in Table
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1120versus their referent counterparts. TPMm/LVM
was also lower in WMA versus referent women
(p  0.0046) but not in men. EFADJ was consis-
tently greater than EFINIT in the referent group as
ell as in the HTN and WMA groups.
Correlation of clinical characteristics and LV indexes
with TPM. Linear correlations between TPM mea-
sures and age, SBP, BMI, and global LV parame-
ters are presented in Table 4. Absolute TPM
volume was inversely and significantly correlated
with age in both sexes for referent participants and
for the offspring as a whole, but the correlation
coefficient was attenuated in the referent group
compared with all participants. TPM/EDV was
also inversely correlated with age in both sexes, but
this was attenuated in the referent group compared
with all participants. TPM/EDV was not associated
with BMI in either sex. There was an inverse
correlation between TPM/EDV and SBP in men
but not in women.
With respect to LV parameters, absolute TPM
increased with greater EDVINIT and ESVINIT in both
sexes. TPM/EDV was weakly and inversely correlated
with EDVINIT and ESVINIT in referent men but not
n men overall or in women overall. Absolute TPMm
ncreased with LVMINIT in both sexes, but TPMm/
LVM was significantly inversely correlated with
relation Coefﬁcients Between Clinical Characteristics, LV Paramet
n the REF Group and the Entire Study Sample
Age BMI SBP
 262)
0.33* 0.004 0.13*
0.15† 0.08 0.22*
0.23* 0.023* 0.31*
(n  423)
0.36* 0.27* 0.017
0.11† 0.0096 0.090
0.24* 0.12† 0.27*
0.21* 0.087† 0.054
0.13* 0.054 0.10†
0.19* 0.17* 0.20*
0.28* 0.27* 0.004
0.12* 0.023 0.055
0.28* 0.13* 0.28*
n  1,494)
0.19* 0.20* 0.007
0.13* 0.013 0.079†
0.23* 0.17* 0.25*s 1 and 2.LVMINIT in both men and women. Finally, TPM
as inversely correlated with EFINIT in both sexes
(r  0.30 in men and r  0.31 in women [p 
0.0001 for both]), but TPM/EDV was not correlated
with EFINIT in either men or women.
Distribution of TPM measures. Table 5 shows the
median and 90th and 95th percentile cutpoints,
according to sex, for TPM, TPM/EDV, and
TPMm/LVM among referent-group offspring.
The 90th and 95th percentile cutpoints of TPM/
EDV ratios were similar across the sexes, whereas
TPMm/LVM was slightly greater in women than
in men for both thresholds. There was minimal
difference between referent-group participants and
the study group as a whole (data not shown). We
elected not to present age-specific percentiles due to
by CMR, and TPM Measures
EDV ESV LVM EF
0.80* 0.70* 0.33* 0.30*
0.14† 0.15† 0.12 0.12
0.39* 0.43* 0.37* 0.30*
0.75* 0.65* 0.51* 0.31*
0.077 0.022 0.050 0.054
0.20* 0.28* 0.33* 0.46*
0.72* 0.57* 0.34* 0.030*
0.024 0.027 0.14* 0.001
0.29* 0.26* 0.39* 0.20*
0.70* 0.58* 0.43* 0.28*
0.07† 0.04 0.11† 0.017
0.17* 0.25* 0.39* 0.26*
0.79* 0.68* 0.57* 0.37*
0.053† 0.043 0.11* 0.0001
0.055* 0.10* 0.42* 0.15*
Table 5. Median (50th) and 90th and 95th Percentile Cutpoints for
TPM, TPM/EDV, and TPMm/LVM Among REF Group Participants
Men Women
50th 90th 95th 50th 90th 95th
TPM, ml 32.3 42.7 45.6 23.9 30.1 33.2
TPM/EDV 0.23 0.27 0.28 0.23 0.27 0.28
TPMm/LVM 0.28 0.38 0.40 0.31 0.40 0.42
TPM/BSA, ml/m2 16.7 21.8 24.2 14.3 18.4 19.5
Abbreviations as in Tables 1 and 2.Table 4. Pearson Cor ers
in Men and Women i
Referent-group men (n
TPM
TPM/EDV
TPMm/LVM
Referent-group women
TPM
TPM/EDV
TPMm/LVM
All men (n  699)
TPM
TPM/EDV
TPMm/LVM
All women (n  795)
TPM
TPM/EDV
TPMm/LVM
All study participants (
TPM
TPM/EDV
TPMm/LVM
*p  0.001, †p  0.05.
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sex-specific categories.
D I S C U S S I O N
In this CMR study of nearly 1,500 community-
dwelling members of the Framingham Heart Study
Offspring cohort, we found that LVM and EF
increased significantly when the TPM were consid-
ered as myocardial mass, whereas EDV and ESV
significantly decreased, compared with the corre-
sponding quantities obtained when the TPM were
considered as part of the LV blood pool. We further
found that TPM decreased with advancing age, and
TPMm/LVM decreased with increasing BMI and
SBP, in both sexes, in a healthy referent cohort
strictly free of obesity, hypertension, and any history
of myocardial infarction or heart failure.
In the context of the current literature. Our average
TPM volume of 23% of LV EDV is consistent with
the literature. However, the majority of previous
reports have considered either papillary muscle
volume or trabecular volume in isolation, and have
not combined them. A canine CMR study by
François et al. (13) found papillary muscle volume
represented 7.7% of LVM. In a 100-participant
subset of the Multi-Ethnic Study of Atherosclerosis
CMR trial, Vogel-Claussen et al. (14) found that
papillary muscles comprised 8.9  0.1% of LVM.
n terms of LV trabeculae, in a study of 20 healthy
ontrols and 20 patients with decreased LV EF,
apavassiliu et al. (7) found that trabeculae com-
rised approximately 10% of LVM in healthy sub-
ects and 14% in patients with systolic dysfunction.
acquier et al. (15) compared the percentage of
rabecular mass with global LVM in 16 controls
12  5%) and the same number of patients in each
roup with hypertrophic cardiomyopathy (12 
%), with dilated cardiomyopathy (11  4%), and
those with LV noncompaction (32  10%). Com-
bining the published 8% to 9% for papillary muscles
and approximately 12% for trabeculations resulted
in findings similar to our data.
As expected, exclusion of TPM from the LV
blood pool and their inclusion with LVM resulted
in lower LV volumes and greater mass. These
findings are similar to the results of Weinsaft et al.
(9) and Papavassiliu et al. (7), who found that EF
was significantly greater when TPM were consid-
ered myocardial mass, but the magnitude of in-
crease was larger in the current study, at about 7 EF
units versus previous results of 3 to 4 EF units.
However, these earlier studies included subjectswith advanced systolic dysfunction, a group not
represented in the current study; therefore, direct
comparisons of change in EF may not be warranted.
Han et al. (8) found a 17% increase in indexed
LVM, a 20% decrease in indexed EDV, and an
average 9-unit increase in EF among a cohort of 30
patients with hypertrophic cardiomyopathy. These
results are broadly comparable to those of the
current study. Also consistent with previous work,
we found that TPM increased with greater LVM,
and now extend this finding by considering TPMm
as a proportion of total LVM, which actually
decreased with greater overall mass.
Areas for additional study. Because this was a cross-
sectional study, it is not possible to determine
whether changes in total LVM are accompanied by
proportional changes in TPM. For example, al-
though it is possible that TPM increase more slowly
in response to a pressure stimulus, such as hyper-
tension or aortic stenosis, than the remainder of
myocardium, it is also possible that those with an
initially lower proportion of TPM are more respon-
sive to that stimulus. Although causality cannot be
inferred from our cross-sectional study, we note
that TPM volume (and thus TPMm) did not
correlate with SBP either in the referent group or in
the study group as a whole, although overall LVM
was significantly correlated with SBP. This suggests
that TPMm may be less responsive to hypertension
than overall myocardial mass. The lack of associa-
tion between TPMm and SBP in our study is
consistent with the MESA (Multi-Ethnic Study of
Atherosclerosis) results (14).
We examined LV mass (and TPM volume) only at
end-diastole, as is common practice. Some readers
may consider that because TPM is the difference
between EDVINIT and EDVADJ, a similar relation
should hold between TPM, ESVINIT, and ESVADJ
due to incompressibility of myocardium, but this was
not the case (Table 2). The numerical difference and
apparent discrepancy are resolved when one considers
that at end-systole, a substantial proportion of the
trabeculae are already tightly apposed against the
compacted myocardium, so that the initial putative
endocardial contours already classify some portion of
the trabeculae as myocardium. Thus, the adjustment
for TPM at end-systole captures only a portion of the
TPM identified at end-diastole.
Currently, LV noncompaction is diagnosed using
CMR based on maximal ratio of noncompacted-to-
compacted layer thickness. The results of this study
do not provide insight as to whether global mea-
sures of trabecular burden, such as the TPM mea-
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1122sures presented here, or regional measures (e.g.,
the aforementioned ratio of noncompacted-to-
compacted thicknesses, the maximal thickness of
the trabeculated layer, the number/location of “hy-
pertrabeculated” segments in the standard 17-
segment model) will have greater value for diagnosis
and prognosis of hypertrabecular disorders of the
myocardium.
Clinical implications. The greater temporal and spa-
tial resolution of current noninvasive imaging tech-
niques, regardless if they are SSFP in CMR or
second-harmonic imaging in echocardiography
(16,17), generally result in better visualization of
LV trabeculae compared with older techniques
(e.g., segmented k-space gradient-echo sequences
in the case of CMR). This can lead to concerns
regarding possible LV noncompaction, particularly
when first adopting the newer techniques. Thus, it
is important to determine what constitutes a “nor-
mal range” of trabeculation.
Petersen et al. (18) have shown that the majority
(approximately 60%) of healthy individuals, as well
as fit athletes, have marked trabeculations, princi-
pally in the apical and select mid-LV segments on
SSFP CMR. Interestingly, they noted a somewhat
lower proportion of patients with hypertensive heart
disease who had segmental hypertrabeculation, an
observation that seems broadly in accord with our
finding that TPMm/LVM is inversely associated
with SBP. Dawson et al. (19) used SSFP CMR to
study a cohort of 120 healthy subjects 20 to 80 years
of age. A trabeculated endocardial layer was present
in at least 1 segment in all subjects, and they found
that the end-diastolic thickness of the trabeculated
layer decreased with advancing age, which is
broadly consistent with our finding of decreased
TPM with greater age. These investigators also
found that the epicardial compacted layer was
thinner in women versus men, but that there was no
difference between sexes in the thickness of thevariable outcomes of isolated left ven- 288–300.the greater TPMm/LVM ratio in women in the
current study.
Although our study was based on a large com-
munity sample without any participants suspected
of having LV noncompaction, we present 90th and
95th percentile upper limits of TPM/EDV and
TPMm/LVM in a healthy referent group. This
information may be useful in future studies of LV
noncompaction or other disorders associated with
abnormal trabecular or papillary muscle volume.
Study limitations. The Framingham Heart Study
ffspring cohort is overwhelmingly white, and the
ajority of subjects were middle-aged or older.
hus, although our results are valid in white sub-
ects in the community, they may not be generaliz-
ble to other age ranges or ethnic groups. In
ddition, our study population did not include
ubjects with advanced systolic dysfunction. Fi-
ally, our CMR findings may not apply to results
btained with non-SSFP CMR sequences and
re unlikely to apply directly to echocardio-
raphic data (20).
C O N C L U S I O N S
Among adults free of clinical cardiovascular disease,
LV trabeculations and papillary muscles occupy
23% of LV EDV in both men and women. Con-
sidering TPM as myocardial mass (as opposed to
LV blood pool) increased LV EF significantly
across the entire study cohort. Reference standards
for “normal values” and comparisons across serial
CMR examinations must take into account not only
the CMR imaging sequence used (6) but also the
image analysis protocol and its treatment of trabe-
culations and papillary muscles.
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